Author information: (1)Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. (2)Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. (3)ECLAT Srl, spin-off of the University of Catania, Via S. Sofia 89, 95123, Catania, Italy. (4)Institute for Research and Innovation, IRIS, Patras Science Park, Patras, Greece. (5)Laboratory of Molecular Biology and Immunology, Department of Pharmacy, University of Patras, Patras, Greece. (6)College of Medicine and Health Sciences, Department of Clinical Biochemistry, Sultan Qaboos University, P.C 123, P.O. Box 35, Khodh, Oman. (7)Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University, Philadelphia, USA. (8)Center for Molecular Medicine and Stem Cell Research, Department of Microbiology and Immunology, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozara Markovica Street, 34000, Kragujevac, Serbia. (9)Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, Via S. Sofia, 87, 95123, Catania, Italy. (10)Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. (11)Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. livolti@unict.it. (12)Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. livolti@unict.it. (#)Contributed equally